Consumer telehealth · Longevity & peptides
AgelessRx
AgelessRx is a direct-to-consumer longevity telehealth company. Clinicians review patients online and ship compounded peptides and related therapies through pharmacy partners. Compounded products here are not FDA-approved anti-aging drugs.
Strong fit
- Consumers comparing smaller DTC longevity platforms that include clinician-guided peptide and related programs
- Patients shopping longevity-oriented telehealth with compounding-pharmacy fulfillment on a smaller DTC platform
- Buyers already comfortable that compounded and off-label longevity therapies need extra diligence
Weak fit
- Anyone treating compounded or off-label longevity therapies as if they were FDA-approved for anti-aging claims
- Patients who need a broad hair/skin/sexual-health mega-brand with heavy consumer advertising
- Buyers looking for provider-side EHR, intake, or ambulatory software (wrong category)
Bottom line
AgelessRx earns a Recommend as a smaller direct-to-consumer longevity telehealth platform with clinician review, home delivery through pharmacy partners, and a peptides-style offering alongside other longevity protocols. The company sits well under the large public DTC brands by scale, which fits how we frame this station. Outcomes for patients are access and protocol convenience more than clinic-grade specialty continuity. Compounded medications are not FDA-approved finished drugs, and many longevity uses are off-label, so pharmacy partners and clinician credentials still belong on the diligence list. On our consumer-telehealth board, AgelessRx scores between Pepti and Henry Meds.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
AgelessRx earns a Recommend as a smaller direct-to-consumer longevity telehealth platform with clinician review, home delivery through pharmacy partners, and a peptides-style offering alongside other longevity protocols. The company sits well under the large public DTC brands by scale, which fits how we frame this station. Outcomes for patients are access and protocol convenience more than clinic-grade specialty continuity. Compounded medications are not FDA-approved finished drugs, and many longevity uses are off-label, so pharmacy partners and clinician credentials still belong on the diligence list. On our consumer-telehealth board, AgelessRx scores between Pepti and Henry Meds.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| AgelessRx | 7.3 | 7.0 |
| Pepti | 7.9 | 7.6 |
| Henry Meds | 6.7 | 6.3 |
Pricing
| Item | Detail |
|---|---|
| Model | Direct-to-consumer consult and medication programs, often with membership-style refills. |
| What usually drives cost | Which protocol you enroll in, dose titration, labs when required, shipping, and membership or follow-up fees. |
| What to ask in diligence | All-in monthly cost at your expected protocol, which compounding pharmacy fills when relevant, and what is compounded versus commercially manufactured. |
| Published pricing | Published starting prices on the vendor treatments pages run from about $25/mo (e.g. metformin, low-dose naltrexone) up through protocols such as microdosing tirzepatide from $159/mo and sermorelin from $99 intro / $149 ongoing on a 3-month plan; women’s hormone care lists a $50/mo membership plus medication cost (as of Sep 2026). Confirm current quote. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get AgelessRx to function | |
| Interest in clinician-guided longevity or peptide-style protocols via telehealth | AgelessRx is a smaller DTC longevity platform, not a hospital specialty clinic. |
| Acceptance that compounded and many off-label longevity uses need extra diligence | Anti-aging marketing claims are not the same as FDA-approved indications. |
| Willingness to complete consult intake and follow clinician lab or monitoring requests | Protocols that skip required labs are not how responsible programs run. |
| Budget for membership-style or protocol pricing plus medication and shipping | Published starting prices vary widely by therapy. |
| Pharmacy-partner comfort for compounded fills when relevant | Ask which pharmacy fills before you treat the brand site as the end of diligence. |
| What will maximize your value | |
| Compare all-in monthly cost at your expected protocol, including membership and labs | Sticker prices on treatment pages omit common add-ons. |
| Verify clinician credentials and compounding pharmacy identity | Smaller DTC brands still need the same partner checks as larger ones. |
| Use refill and follow-up cadence deliberately after the first shipment | Longevity protocols fail when patients self-adjust without review. |
| Keep scope honest: access and convenience, not clinic-grade specialty continuity | That framing matches how outcomes work here. |
| Re-check published prices when dose or protocol changes | Tirzepatide, sermorelin, and hormone programs price differently. |
| Deal-breakers | |
| You treat compounded or off-label longevity therapies as if they were FDA-approved for anti-aging claims. | |
| You need a broad hair/skin/sexual-health mega-brand instead of a longevity-focused platform. | |
| You want provider-side EHR, intake, or ambulatory software. | |
| You will not complete clinician review or required labs. | |
| You are unwilling to diligence pharmacy partners. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Sign-up → clinician review | Typically 1–4 days after intake and any required questionnaire or lab ordering |
| 2 | Clinician review → medication ships | Several days after approval, depending on pharmacy partner and protocol |
| 3 | First order → ongoing refill cadence | Membership or multi-month plans often steady within 2–6 weeks once shipping and dose settle |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.